Skip to main content
. 2021 Feb 20;35(6):1281–1290. doi: 10.1007/s10557-021-07151-9

Fig. 5.

Fig. 5

Coronary endothelial outgrowth cells do not incorporate into murine vessels in vivo. Immunohistochemistry of subcutaneously implanted sponges embedded with CEO cells (ac), EOCs (df), and HUVECs (gi). Sections were stained with antibodies cross-reactive to both mouse and human antigens (red) or specific to human antigens (green) using 4',6-diamidino-2-phenylindole (DAPI) as a counterstain. Auto-fluorescent erythrocytes are presence in vessel lumen demonstrates the vessels were contiguous with the host circulation. Scale bars 50 μm. In contrast to late endothelial outgrowth cells (EOCs) and human umbilical vein endothelial cells (HUVECs), coronary endothelial outgrowth (CEO) cells did not incorporate into murine vessel (j) (one-way analysis of variance P = 0.019; Bonferroni post-test *P < 0.05 for CEO cells versus HUVECs. n = 4–10)